Medtronic Non-GAAP EPS of $1.13 beats by $0.01, revenue of $7.37B beats by $160M

Aug. 23, 2022 6:48 AM ETMedtronic plc (MDT)By: Niloofer Shaikh, SA News Editor1 Comment
  • Medtronic press release (NYSE:MDT): Q1 Non-GAAP EPS of $1.13 beats by $0.01.
  • Revenue of $7.37B (-7.8% Y/Y) beats by $160M.
  • "The company continues to execute in a challenging environment, delivering organic revenue above our guidance," said Geoff Martha, Medtronic chairman and chief executive officer. "As we look ahead, our supply chain is improving, we have several near-term pipeline catalysts approaching, and we are confident in our ability to accelerate growth."
  • The company continues to expect organic revenue growth in its fiscal year 2023 in the range of 4% to 5%. If recent foreign currency exchange rates hold, fiscal year 2023 revenue growth would be negatively affected by approximately $1.4B to $1.5B versus the previously stated $1.0 to $1.1B impact.
  • The company continues to expect FY2023 diluted non-GAAP EPS in the range of $5.53 to $5.65, including an estimated 17 to 22 cent negative impact from foreign currency vs. consensus of $5.57.

Recommended For You

Comments (1)

To ensure this doesn’t happen in the future, please enable Javascript and cookies in your browser.
Is this happening to you frequently? Please report it on our feedback forum.
If you have an ad-blocker enabled you may be blocked from proceeding. Please disable your ad-blocker and refresh.